Search News

News Results

There are 988,725 News Results

Mar 8, 2018

CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology

Mar 29, 2018

ProfNet Experts Available on Cognitive Behavioral Therapy, Psychology of Privacy, More

May 21, 2018

TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., from the MD Anderson Cancer Center

Jun 12, 2018

2018 Nashville "Thunder on the Cumberland" Press Release

NASHVILLE, June 12, 2018 /PRNewswire-PRWeb/ -- Follow the NGK Spark Plugs Formula One Powerboat Championship to Nashville, Tennessee on Father's Day weekend, Friday, June 15, and Saturday, June 16, 2018,...

Jul 12, 2018

Sprint's Industry-Leading Unlimited Plans Just Got Even Better! New Unlimited Plans Include Features Customers Love for the Best Price

Customers can choose from Unlimited Plus, Unlimited Basic, Unlimited Military or Unlimited 55+

Aug 1, 2018

Hackensack Meridian Health and Carrier Clinic Plan to Merge to Enhance Behavioral Health in Tri-State Area

EDISON, N.J. and BELLE MEAD, N.J., Aug. 1, 2018 /PRNewswire/ -- Hackensack Meridian

Aug 21, 2018

Dell EMC Launches PowerEdge MX, Offering Agile, Flexible, Modular Infrastructure for IT Transformation

HOPKINTON, Mass., Aug. 21, 2018 /PRNewswire/ --

Jun 7, 2017

Argan, Inc. Reports First Quarter Results

Argan, Inc.

Jun 2, 2017

ARMO BioSciences Announces Promising Response Rates and Survival Data in Patients with Advanced NSCLC and RCC from Phase 1/1b Trial for Immunotherapy AM0010 with Checkpoint Inhibitors

REDWOOD CITY, Calif., June 3, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) in...

Jul 2, 2017

'All Men Are Created Equal' -- Unless Labeled 'Mentally Ill'

LOS ANGELES, July 3, 2017 /PRNewswire/ -- Mental health industry watchdog, Citizens Commission on Human Rights (CCHR) , disclosed that thousands of Americans every year lose their Constitutional rights under...

Stories of the day

Oct 10, 2025
INVISIO signs framework agreement worth up to SEK 365 million with Netherlands...
The agreement will run initially for five years, with an option for two one-year extensions
Oct 10, 2025
Rheinmetall to supply Leopard 1-based Skyranger 35 to Ukraine – contract value...
The systems will be financed by an EU member state using proceeds from frozen Russian assets.
Oct 14, 2025
DroneSentry Solution Recognised as NPSA Rated
DroneShield’s extensive range of counter-drone solutions are available exclusively through BT within the UK.
Oct 14, 2025
RTX's Raytheon begins initial production of SharpSight surveillance radar
This next-generation system will provide high-altitude, real-time, high-resolution imaging with wide-area search and tracking for land and maritime surveillance, operating day or night in any weather condition.